Prémiový dluhový cenný papír PHARMA AUTOCALL 3 |
|
ISIN: XS2658514794 |
2024/07/17 00:00:00 | |
---|---|
Bid | Ask |
104.75 | - |
Minimum yield | - |
Difference | ![]() |
General attributes | |
---|---|
Type of bond | Structured bonds and notes |
Bond style | senior |
Issuer type | financial institution |
Country of issue | DE |
Current coupon | - |
Coupon style | variable |
Coupon payment date | 2026/11/16 |
Coupon payment period | at maturity |
Yield to maturity p.a. (before capital gains tax) | - |
Value date | 2023/10/31 |
Maturity | 2026/11/16 |
Repayment value | 0 |
Currency | CZK |
Nominal value | 10,000 |
Capital gains tax | - |
Accrued Interest | - |
|
Performance since inception. Performances under 12 month have only little informative value because of the short maturity. Information about previous performance does not guarantee future performance. Source: Česká spořitelna, a. s. |
Advantages | Details you should be aware of |
What does PDCP PHARMA AUTOCALL 3 offer?
|
Please note that the target market of this investment instrument is listed below. If you do not meet any of the listed parameters, you may be outside the specified target market!
The target market defines the set of investors (retail clients) for whom the investment product is intended.
This investment product is intended for investors who:
* have sufficient knowledge and/or experience regarding structured products and shares.
* seek investment profit
* are able to accept a level of risk that is in accordance with the risk indicator of the product specified in General attributes.
* In the event of an unfavorable development of the investment, they are able to bear the possible loss, which is ilustrated by performance scenarios, see Key Information Document (KID).
* are interested in holding the product until the maturity specified in General attributes.
This investment product is not intended for investors (negative product target market), who:
The client's compatibility with the product's target market will be evaluated during the purchase process.
----------------------------------------------------------
|
Description | |
---|---|
PDCP PHARMA AUTOCALL 3 allows to obtain an attractive annual yield of 7.75% (see Note) at early maturity. While the total yield for its approximately three-year duration is derived from the performance of the underlying index – MSCI World IMI New Pharma Select 5% Decrement Index.
The payout of the yield and nominal value of PDCP PHARMA AUTOCALL 3 is derived from the development of the underlying asset – MSCI World IMI New Pharma Select 5% Decrement Index – focusing on shares of innovative pharmaceutical companies. In addition, the construction of PDCP PHARMA AUTOCALL 3 enables its automatic early repayment even in case of slight decline or stagnation of the price of the underlying index. PDCP PHARMA AUTOCALL 3 can already be paid early after the first year or the following year depending on the fulfilment of the terms for early repayment.
Issuer: Goldman, Sachs & Co. Wertpapier GmbH
Guarantor: The Goldman Sachs Group, Inc. (Standard & Poor's BBB+ / Moody's A2 / Fitch A)
Underlying index: MSCI World IMI New Pharma Select 5% Decrement Index
Subscription period: 27 September 2023 (9.00)–24 October 2023 (23.59)
You will find more information in the leaflet |
|
Payment notes | |
---|---|
How does PDCP PHARMA AUTOCALL 3 work?
You will find more information in the leaflet |
|
Settlement | |
---|---|
|
|
Secondary market | |
---|---|
----------------------------------------- Note: PDCP PHARMA AUTOCALL 3 pays out one-off any potential yields at its early or regular maturity date, while compound interest bearing is not applied. |
|
Disclaimer |
---|
In the period before maturity, the bond price can fluctuate above and below the bond face value depending on the development of the interest rate and underlying asset. A bond can ben sold even before the maturity date, for the price pursuant to the pricelist of the issuer. Our consultants will give you detail information on the advantages and risks of investment in bonds. The information sources used are generally regarded as reliable, although Česká spořitelna and Erste Group Bank AG cannot guarantee the correctness and completeness of the information contained therein. The aim of this web page is to give information on the services and products contained therein; it is not a binding proposal establishing any rights and obligations for participants. All information you can find here is of informative nature only. Before using the web page for investment, a specialized Česká spořitelna consultant should be consulted. |